Latest / Stock Movers / Goldman Higher on Earnings; Apple Tariff Relieve; Pfizer Drug Pivot
Transcript
- 0:02Speaker 1: Bloomberg Audio Studios, podcasts, radio news, The Stock Movers podcast,
- 0:10Speaker 1: your roundup of companies making moves in the stock market,
- 0:14Speaker 1: harnessing the power of Bloomberg Data.
- 0:17Speaker 2: Now we need to look at some sucks they are
- 0:20Speaker 2: on the move today. We're joined by Lisa Matteo. Lisa,
- 0:23Speaker 2: what do you have?
- 0:23Speaker 1: All right?
- 0:23Speaker 3: So I started with Goldman Sacks has been riding this
- 0:25Speaker 3: wave of volatility. It chairs have been up as much
- 0:27Speaker 3: as two percent. Stock traders posted their highest quarterly revenue
- 0:31Speaker 3: haul on record, a beat on equities trading revenue for
- 0:34Speaker 3: the first quarter, where was twenty seven percent from a
- 0:36Speaker 3: year earlier, almost four point two billion for the first
- 0:39Speaker 3: three months of the year. It also announced and this
- 0:42Speaker 3: was biggest share buyback program of up to forty billion dollars.
- 0:45Speaker 3: But what it does. It really follows a record year
- 0:47Speaker 3: for Goldman in twenty twenty four. It lifted its revenue
- 0:50Speaker 3: in the division by almost fifty percent. And everybody's always
- 0:53Speaker 3: focused on what the CEO says. Well, David Solomon said, yes,
- 0:57Speaker 3: they're entering the second quarter with a different operating environment.
- 0:59Speaker 3: But Goldman, he says, it is confident it's ability to
- 1:02Speaker 3: continue to support their clients.
- 1:04Speaker 2: Goldman Sachs share buyback for twenty five point two percent
- 1:09Speaker 2: of market cap forty billion for Apple is one point
- 1:13Speaker 2: x percent. It's just it's Apple's tea swings compared to
- 1:16Speaker 2: what we got going after Goldman.
- 1:18Speaker 1: Gosh.
- 1:18Speaker 3: Now, since you mentioned Apple, I'm gonna go there. Okay,
- 1:21Speaker 3: It's share had been up as much as secure person.
- 1:24Speaker 3: Thank you for that, benefiting from the tariff news. So
- 1:27Speaker 3: here's the background. Right, it started Friday, you had the
- 1:29Speaker 3: White House saying it was exempting some tech products from tariffs.
- 1:32Speaker 3: Then on Sunday, President Trump came in and said it
- 1:35Speaker 3: was temporary and that earlier exemptions are really just moving
- 1:38Speaker 3: into a different tariff bucket. But it's not just Apple
- 1:42Speaker 3: that's moving higher, because that still is companies like Dell HP.
- 1:45Speaker 3: Then you have the chip sector, you have Nvidia, Advanced
- 1:48Speaker 3: micro Devices, Broadcom, Qualcom, even Apple suppliers in Asia they
- 1:53Speaker 3: are recovering, like fox Con you know they manufacture the iPhones.
- 1:57Speaker 3: They closed about three percent higher too.
- 1:59Speaker 2: One more.
- 2:00Speaker 3: All right, So Pfizer, we heard of OBC shots, right, Well,
- 2:03Speaker 3: a lot of people you know have those, but Pfizer
- 2:05Speaker 3: was working on OBCD pill and that's key It was
- 2:09Speaker 3: closely watched by investors. They were waiting for it, but
- 2:12Speaker 3: now Pfizer saying they're going to stop working on it.
- 2:15Speaker 3: It was linked to this potentially drug related liver injury
- 2:18Speaker 3: and one patient from a clinical trial. So that's the
- 2:21Speaker 3: reason why it's such a blow. I mean Pfizer, they
- 2:24Speaker 3: were already behind in the competition, right, They made competing
- 2:27Speaker 3: in the NBCD market kind of key because they were
- 2:29Speaker 3: trying to come back from this COVID comeback.
- 2:31Speaker 2: You know.
- 2:32Speaker 3: So their shares have been lower, but who it is
- 2:35Speaker 3: benefiting is their competition like no Vo nor Is their
- 2:39Speaker 3: ADRs up about three percent, and Eli Lilly their shares
- 2:42Speaker 3: have been up as much as two percent, so not
- 2:44Speaker 3: too bad. Last one I want to mention too quickly
- 2:47Speaker 3: before we go is Intel it shares. The company's really
- 2:50Speaker 3: been struggling, right, you know, like it lost market shared
- 2:53Speaker 3: to rivals in recent years, missed the shift to AI accelerators.
- 2:56Speaker 3: Market's now dominated by Nvidia, so it's spinning off non
- 3:00Speaker 3: central businesses and assets. For example, it's a great to
- 3:03Speaker 3: sell fifty one percent of its Steak and Programmable Chips
- 3:06Speaker 3: unit Altera to silver Lake Management. The deal should close
- 3:10Speaker 3: in the second half of twenty twenty five, Intel continuing
- 3:13Speaker 3: to hold that forty nine percent stake in the business,
- 3:15Speaker 3: but it values Altera at eight point seventy five billion.
- 3:19Speaker 3: Intel back in two fifteen, they paid about seventeen billion
- 3:23Speaker 3: for the company, so you see the difference.
- 3:27Speaker 2: That's important statistic that they never talk about.
- 3:30Speaker 1: The Stock Movers podcast from Bloomberg Radio. Check back with
- 3:35Speaker 1: us throughout the day for the latest roundup of companies
- 3:37Speaker 1: making news on Wall Street and for the latest market
- 3:40Speaker 1: moving headlines. Listen to Bloomberg Radio Live, catch us on YouTube,
- 3:45Speaker 1: Bloomberg dot com, and on Applecarplay and Android Auto with
- 3:48Speaker 1: the Bloomberg Business app.